SCHEMBL20182354

SCHEMBL20182354

CCC(/C(=C/Nc1ccccc1F)N=N)n1c(Br)c(-c2cnc(C(F)(F)F)nc2)c2c(N)ncnc21

nearest known ligand 0.41

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
CFTR P13569 16/20 0.41
LRRK2 Q5S007 1/20 0.33
KDR P35968 1/20 0.33
TEK Q02763 1/20 0.33
RET P07949 1/20 0.32
RIPK1 Q13546 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20182355 0.94 CFTR (0.38) CFTRLRRK2RETRIPK1
SCHEMBL20182356 0.93 CFTR (0.39) CFTRRIPK1
SCHEMBL20182280 0.91 CFTR (0.38) CFTRLRRK2KDRTEKRET
SCHEMBL20182263 0.91 CFTR (0.40) CFTRLRRK2RIPK1
SCHEMBL20182269 0.85 CFTR (0.38) CFTRLRRK2RIPK1
SCHEMBL20182197 0.85 CFTR (0.43) CFTRKDRTEK
SCHEMBL20181896 0.83 CFTR (0.42) CFTRRIPK1
SCHEMBL20182278 0.83 CFTR (0.37) CFTRRETRIPK1
SCHEMBL20182220 0.83 CFTR (0.39) CFTRLRRK2KDRTEKRET
SCHEMBL20182285 0.79 CFTR (0.41) CFTRKDRTEK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018094137-A1 PYRROLOPYRIMIDINES AS CFTR POTENTIATORS CYSTIC FIBROSIS FOUNDATION THERAPEUTICS INC. (US) 2018-05-24 WO disclosed